U.S. Supreme Court Hears Bayer Appeal Over Roundup Cancer Lawsuits Filed by John Durnell

The U.S. Supreme Court heard arguments Monday in a case that could determine whether thousands of cancer patients can keep suing the manufacturers of the popular weed killer glyphosate, known as Roundup.

“Monsanto, a subsidiary of the German agrochemical giant Bayer, disclosed an agreement that could reach up to $7”

Blick

The dispute centers on whether a federal law that regulates the sale and marketing of herbicides preempts state-level lawsuits against manufacturers, with the case centering on whether federal or state actors decide what warning labels should be put on herbicides.

Blick

The main plaintiff is a Missouri man named John Durnell, who alleged that two decades of exposure to the chemical caused him to develop blood cancer, and a jury found Bayer had failed to warn him and awarded him $1.25 million in damages.

The Trump administration, which has called Roundup safe, is siding with Bayer, and the case is framed around whether federal law blocks state failure-to-warn claims.

The Washington Post described the Supreme Court as “wrestled with whether federal law preempts judges and juries” from weighing claims from “tens of thousands of cancer patients.”

STAT similarly said the Supreme Court “seemed divided Monday over whether to block thousands of lawsuits” alleging Roundup maker Monsanto failed to warn people it could cause cancer.

The Detroit News reported that Bayer appealed a jury verdict in Missouri state court awarding $1.25 million to Durnell, and that Paul Clement argued for Bayer that federal pesticide law should prevent failure-to-warn claims brought under state law from moving forward.

The legal fight is rooted in long-running controversy over glyphosate’s cancer risk and in how regulators and courts handle warning labels.

Democracy Now! said critics of Roundup have long alleged a link between the herbicide and cancer, and it traced the product’s development to Monsanto, which was bought by Bayer in 2018.

C&EN

It also described a key scientific trigger: “In 2015, the World Health Organization released a landmark assessment saying glyphosate is ‘probably’ carcinogenic,” which “It sparked all those lawsuits,” according to Nate Halverson.

STAT added that the World Health Organization’s International Agency for Research on Cancer classified the chemical as “probably carcinogenic” in 2015, while the Environmental Protection Agency has determined that it’s not likely to be carcinogenic to humans when used as directed.

STAT further said the EPA approved a label without a cancer warning, and Bayer argues it is required to follow those federal standards rather than state laws that Durnell and others have sued under.

The Guardian described how the jury found Monsanto failed to warn the plaintiff that glyphosate could cause cancer, while Bayer maintained its products don’t cause cancer and asked the Supreme Court to rule that it cannot be held liable for failing to warn of a cancer risk if the EPA has not found such a risk exists and not required such a warning.

USA Today similarly said the Environmental Protection Agency “has not determined that Roundup poses a cancer risk and does not require a warning label saying it does,” and that the justices are deciding whether that means Roundup users who’ve developed cancer cannot sue by claiming the weed killer violates state laws about dangerous products.

During the hearing, both sides framed the question as one of federal uniformity versus state authority to respond to alleged health risks.

Paul Clement, arguing for Bayer, told the justices that federal law governing pesticides should prevent failure-to-warn claims like Durnell’s that are brought under state law from moving forward in court, and the Detroit News quoted him saying, “A Missouri jury imposed a cancer-warning requirement that (the) EPA does not require. That additional requirement is preempted.”

The Guardian reported Clement told the justices that provisions within FIFRA are “crystal clear” in barring pesticide makers from changing safety warnings on a pesticide label without EPA approval, and it quoted him saying, “Congress plainly wanted uniformity when it came to the safety warnings on a pesticide’s label.”

The U.S. government’s position was presented through Sarah Harris, and the Guardian quoted her telling the justices that states can’t try to “second-guess or undermine” the EPA’s process.

On the other side, Durnell’s lawyer Ashley Keller argued that the United States is wrong and that FIFRA does not provide the blanket authority claimed by Monsanto with “pre-emptive force,” according to the Guardian, and USA Today quoted Keller saying, “Regardless of what the EPA says, they are not a safe harbor.”

NPR described how Paul Clement told the justices, “You shouldn’t let a single Missouri jury second guess that judgment,” while NPR also quoted Sarah Harris arguing, “State law must give way.”

The justices’ questions reflected concern about both uniformity and timing, with USA Today quoting Justice Brett Kavanaugh asking, “Do you think it’s uniformity when each state can require different things?” and quoting Chief Justice John Roberts probing whether state lawsuits could be a faster way of reacting to changing information.

In the middle of these exchanges, the case’s procedural posture remained central: the Supreme Court was not evaluating whether glyphosate causes cancer, but who decides what appears on warning labels and whether states have a role after the EPA weighs in, NPR said.

Coverage across outlets emphasized different aspects of the same Supreme Court dispute, particularly the scale of litigation, the regulatory timeline, and the implications for future lawsuits.

STAT highlighted the Supreme Court’s internal division and described the case as coming after “a tidal wave of litigation” that included “some multibillion-dollar verdicts against the global agrochemical manufacturer Bayer,” while it also noted that several justices seemed sympathetic to Bayer’s argument that it can’t be sued under state law because federal regulators have found Roundup likely doesn’t cause cancer.

Noticias de Puerto Rico hoy

USA Today foregrounded the justices’ questions about uniformity and timing, quoting Justice Kavanaugh’s “Do you think it’s uniformity when each state can require different things?” and quoting Chief Justice John Roberts on whether state lawsuits are “responsive to the new information more quickly than the federal government is.”

The Guardian focused on the legal mechanics of preemption and quoted Clement’s “crystal clear” reading of FIFRA, while also describing the EPA’s position that glyphosate is “unlikely” to be carcinogenic and warning that a Monsanto win would make it harder for consumers to file lawsuits “not just against Monsanto, but against other pesticide makers as well.”

NPR framed the case as a dispute over labels and decision-making authority, stating that “The justices will not be evaluating whether glyphosate causes cancer,” and it quoted Paul Clement’s argument that “You shouldn’t let a single Missouri jury second guess that judgment.”

Democracy Now! added a different dimension by tying the Roundup debate to a separate investigation about the U.S. Forest Service expanding its use of Roundup, with Nate Halverson saying, “the fastest-growing use is actually now for forestry,” and describing a finding that “90% of forest spraying was happening” in Southern states.

Even within the Roundup coverage, the outlets differed in how they described the stakes: The Guardian said Bayer’s favorable ruling would help it put an end to litigation, while STAT said Bayer has set aside $16 billion to settle cases and that the company proposed a major settlement earlier this year.

The Detroit News and C&EN both emphasized the legal framework of FIFRA and preemption, with C&EN describing Clement’s “preempted twice over” argument and quoting Clement’s language that the claim “is preempted twice over.”

Taken together, the reporting shows that while all outlets track the same Supreme Court hearing, they foreground different angles—regulatory timing, uniformity, litigation scale, and broader policy context.

The consequences of the Supreme Court’s decision are described across outlets as potentially ending or reshaping a large portion of Roundup litigation, with Bayer arguing that a ruling in its favor would largely bring the remaining cases to an end.

“Opinion Magazine Holidays Newsletters Dark mode”

Noticias de Puerto Rico hoy

STAT said the company has set aside $16 billion to settle cases and that it proposed a major settlement earlier this year, while it also reported that Bayer has faced more than 100,000 Roundup claims, mostly from home users, and that it stopped using glyphosate in Roundup sold in the U.S. residential lawn and garden market.

NPR

The Detroit News reported that Bayer announced in February a proposed $7.25 billion settlement to resolve tens of thousands of current and future lawsuits, and it said the settlement would not affect claims stemming from pending appeals or that fall outside the deal, which the company said amounted to nearly $1 billion.

C&EN likewise described a “flood” of glyphosate lawsuits, stating that Durnell’s case is one of more than 100,000 in the US seeking to hold Bayer liable under state laws for failing to warn of alleged cancer risks from Roundup exposure.

The Guardian said Bayer has spent the last decade fighting more than 100,000 lawsuits and that it has paid out billions of dollars in jury awards and settlements, while it also quoted Bayer’s statement after the hearing about “a patchwork of 50 different warning labels.”

USA Today described the fight as playing out as a proposed $7.25 billion class action settlement could resolve many of the lawsuits, and it said uncertainty over how the Supreme Court will rule could be an extra inducement for people suing Bayer to accept the pending deal.

Beyond the courtroom, Democracy Now! described a separate policy controversy over glyphosate use in forestry, with Nate Halverson saying the fastest-growing use is now for forestry and that “companies are using it right after they log the land, spraying glyphosate everywhere.”

The Supreme Court’s timeline is also consistent across outlets: The Guardian said the Supreme Court is expected to decide the case by the end of June, and the Detroit News said a Supreme Court ruling is expected by the end of June.